HARD SCIENCE ON LYME: Are FDA-approved tests better or worse?
The FDA gave its blessing to Lyme tests that miss as many as half the cases or more. The CDC thinks this should be good enough for patients. But patients insist on tests with better sensitivity from specialty labs in spite of having to pay out of pocket. Why is the government trying to prevent them from using all the tools in the arsenal when failure to diagnose has profound, life-altering consequences?
